Send Inquiry

Request To Call Back

Atenolol IP

Get a Price/Quote

MOQ : 100 Kilograms

Atenolol IP Specification

EINECS No
249-028-3

Loss on Drying
NMT 0.5%

Ph Level
4.5-6.5 (1% aqueous solution)

Smell
Odorless

Taste
Bitter

Molecular Weight
266.34 g/mol

Heavy Metal (%)
NMT 0.001%

Particle Size
NMT 10 microns

Structural Formula
[structural formula displayed on request]

Poisonous
Non-poisonous at therapeutic dose

HS Code
29420090

Melting Point
152-156C

Shelf Life
36 months

Molecular Formula
C14H22N2O3

Solubility
Slightly soluble in water, sparingly soluble in ethanol (96%), practically insoluble in methylene chloride

Color
White

Boiling point
Not applicable (decomposes)

Storage
Store in a cool, dry place, protected from light

Medicine Name
Atenolol IP

Chemical Name
Atenolol

CAS No
29122-68-7

Type
Active Pharmaceutical Ingredient (API)

Grade
IP (Indian Pharmacopoeia)

Usage
Antihypertensive drug, Beta-blocker

Purity(%)
Assay NLT 99.0%

Appearance
White or almost white powder

Physical Form
Solid

Chloride Content
NMT 0.014%

pH of 1% Solution
4.5-6.5

Packaging
HDPE drum or as per customer requirement

Identification
By IR, meets IP requirements

Optical Rotation
Not more than +0.1 to -0.1 (meets IP standard)

Related Substances
Total impurities NMT 0.5%

Residual Solvents
Complies with ICH guidelines

Formulation Compatibility
Suitable for tablet, capsule, and oral solution formulations

Microbial Limit
Complies with IP requirements

Atenolol IP Trade Information

Minimum Order Quantity
100 Kilograms

Supply Ability
1000 Kilograms Per Week

Delivery Time
7 Days

Atenolol IP About

Atenolol IP, a crowning achievement in antihypertensive therapy, is an unassailable beta-blocker sourced and manufactured with meticulous compliance to IP standards. Boasting an ineffable level of purity (Assay NLT 99.0%), it retains customizable packaging-typically in HDPE drums or as per client requirements-for greater procurement flexibility. Hot-selling and versatile, it seamlessly integrates with tablet, capsule, or oral solution formulations. With strict control of chloride content, related substances, and heavy metals, each batch assures unwavering quality and safety. Ideal for manufacturers, wholesalers, and distributors who demand distinction in every shipment.

Comprehensive Uses and Audience for Atenolol IP

Atenolol IP is primarily used as an antihypertensive agent and beta-blocker, offering reliable cardiovascular support. This API is favored by pharmaceutical manufacturers, hospitals, pharmacies, and research institutions globally. Valued for its customizable options and stringent quality controls, Atenolol IP's extra features include high assay values, minimized impurities, and compatibility across various pharmaceutical forms, ensuring adaptable solutions for diverse medical needs and formulations.

Market Value, Domestic Reach, and Payment Conveniences

Atenolol IP holds significant market value within India's robust pharmaceutical sector, with frequent shipment to leading pharmaceutical hubs. Shipped goods are consistently delivered in optimal condition, adhering to rigorous standards. Clients can expect multiple payment terms-including advance payments, LC, and others-for procurement convenience. Sample availability ensures confident sourcing and allows clients to verify quality prior to bulk orders, establishing trust in every market transaction.

FAQ's of Atenolol IP:

Q: How is Atenolol IP typically procured and what packaging options are offered?

A: Atenolol IP can be conveniently procured directly from manufacturers, suppliers, or distributors. It is generally packaged in HDPE drums but can also be customized according to specific customer requirements.

Q: What makes Atenolol IP a hot-selling product in the pharmaceutical sector?

A: Its unassailable purity, compliance with Indian Pharmacopoeia (IP) standards, low impurity levels, and broad formulation compatibility make Atenolol IP highly sought after by manufacturers and suppliers.

Q: Where is Atenolol IP mainly used and who benefits from it?

A: Atenolol IP is mainly used in antihypertensive medications. Beneficiaries include pharmaceutical companies, hospitals, clinics, and research organizations requiring a reliable and pure beta-blocker API.

Q: What is the process for quality assurance and testing of Atenolol IP?

A: Quality is assured through IR identification, checks for chloride content, total impurities, optical rotation, and compliance with ICH guidelines for residual solvents and microbial limits, alongside specific IP requirements.

Q: When can clients expect delivery and is sample verification available?

A: Delivery timelines are determined once order details are confirmed, with prompt shipment prioritizing product integrity. Samples are available for clients wishing to verify quality before final procurement.

Q: How does Atenolol IP ensure safety and compatibility in medicinal formulations?

A: Atenolol IP's low heavy metal content, minimal loss on drying, and controlled particle size ensure ineffable safety and compatibility across tablet, capsule, and oral solution formulations.

Tell us about your requirement